Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands		Total	Common Stock [Member]		Common Stock [Member] Series D Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member]		Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
Beginning balance at Dec. 31, 2020		$ 470,052	$ 129	[1]		$ 929,125	[1]	$ (467,878)	$ 0	$ 8,676
Beginning balance, Shares at Dec. 31, 2020	[1]		1,288,595,876
Issuance of common stock upon exercise or vesting of equity awards		39				39	[1]
Issuance of common stock upon exercise or vesting of equity awards, Shares	[1]		4,097,924
Issuance of warrants to purchase Series D convertible preferred stock		300				300	[1]
Issuance of common stock upon exercise of Public Warrants, Shares	[1]				771,545
Stock-based compensation expense		14,637				14,637	[1]
Foreign currency translation		0
Net loss		(129,242)						(127,510)		(1,732)
Ending balance at Jun. 30, 2021		355,786	$ 129	[1]		944,101	[1]	(595,388)	0	6,944
Ending balance, Shares at Jun. 30, 2021	[1]		1,293,465,345
Beginning balance at Mar. 31, 2021		395,569	$ 129	[1]		929,420	[1]	(541,447)	0	7,467
Beginning balance, Shares at Mar. 31, 2021	[1]		1,291,413,193
Issuance of common stock upon exercise or vesting of equity awards		12				12	[1]
Issuance of common stock upon exercise or vesting of equity awards, Shares	[1]		1,280,607
Issuance of warrants to purchase Series D convertible preferred stock		150				150	[1]
Issuance of common stock upon exercise of Public Warrants, Shares	[1]				771,545
Stock-based compensation expense		14,519				14,519	[1]
Foreign currency translation		0
Net loss		(54,464)						(53,941)		(523)
Ending balance at Jun. 30, 2021		355,786	$ 129	[1]		944,101	[1]	(595,388)	0	6,944
Ending balance, Shares at Jun. 30, 2021	[1]		1,293,465,345
Beginning balance at Dec. 31, 2021		1,567,379	$ 161			3,804,844		(2,297,925)	(1,715)	62,014
Beginning balance, Shares at Dec. 31, 2021			1,611,392,152
Issuance of common stock upon exercise or vesting of equity awards		78	$ 2			76
Issuance of common stock upon exercise or vesting of equity awards, Shares			18,983,348
Tax withholdings related to net share settlement of equity awards, Shares			(295,621)
Tax withholdings related to net share settlement of equity awards		(981)				(981)
Issuance of common stock upon exercise of Public Warrants, Shares			30
Issuance of common stock for business acquisitions		20,128	$ 1			20,127
Issuance of common stock for business acquisitions, shares			5,554,360
Deconsolidation of subsidiary		(28,783)								(28,783)
Stock-based compensation expense		1,276,179				1,273,952				2,227
Foreign currency translation		(3,781)							(3,781)
Net loss		(1,263,163)						(1,259,330)		(3,833)
Ending balance at Jun. 30, 2022		1,567,056	$ 164			5,098,018		(3,557,255)	(5,496)	31,625
Ending balance, Shares at Jun. 30, 2022			1,635,634,269
Beginning balance at Mar. 31, 2022		1,614,048	$ 162			4,471,418		(2,888,430)	(2,355)	33,253
Beginning balance, Shares at Mar. 31, 2022			1,622,054,156
Issuance of common stock upon exercise or vesting of equity awards		2	$ 1			1
Issuance of common stock upon exercise or vesting of equity awards, Shares			8,025,753
Issuance of common stock for business acquisitions		20,128	$ 1			20,127
Issuance of common stock for business acquisitions, shares			5,554,360
Stock-based compensation expense		606,589				606,472				117
Foreign currency translation		(3,141)							(3,141)
Net loss		(670,570)						(668,825)		(1,745)
Ending balance at Jun. 30, 2022		$ 1,567,056	$ 164			$ 5,098,018		$ (3,557,255)	$ (5,496)	$ 31,625
Ending balance, Shares at Jun. 30, 2022			1,635,634,269

[1] Balances presented were retroactively restated for the reverse recapitalization as described in Note 1.